Sensei Biotherapeutics Inc (SNSE)
0.5555
0.00 (0.00%)
USD |
NASDAQ |
Sep 27, 16:00
0.5438
-0.01
(-2.11%)
After-Hours: 20:00
Sensei Biotherapeutics Cash from Investing (Quarterly): 6.907M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 6.907M |
| March 31, 2024 | 5.77M |
| December 31, 2023 | 8.262M |
| September 30, 2023 | 8.312M |
| June 30, 2023 | 19.53M |
| March 31, 2023 | 2.312M |
| December 31, 2022 | 16.04M |
| September 30, 2022 | 8.517M |
| June 30, 2022 | 13.20M |
| Date | Value |
|---|---|
| March 31, 2022 | 12.19M |
| December 31, 2021 | 5.612M |
| September 30, 2021 | -0.482M |
| June 30, 2021 | -147.76M |
| March 31, 2021 | -0.487M |
| December 31, 2020 | -0.316M |
| September 30, 2020 | -0.836M |
| June 30, 2020 | -0.199M |
| March 31, 2020 | -0.052M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-147.76M
Minimum
Jun 2021
19.53M
Maximum
Jun 2023
-2.416M
Average
5.691M
Median
Cash from Investing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -0.144M |
| Theriva Biologics Inc | -0.001M |
| Oragenics Inc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.792M |
| Cash from Financing (Quarterly) | -0.18M |
| Free Cash Flow | -24.38M |
| Free Cash Flow Per Share (Quarterly) | -0.2351 |
| Free Cash Flow Yield | -174.4% |